Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Top Stories > Biden says he is ‘doing well,’ working after testing positive for COVID
    Top Stories

    Biden says he is ‘doing well,’ working after testing positive for COVID

    Published by Jessica Weisman-Pitts

    Posted on July 22, 2022

    6 min read

    Last updated: February 5, 2026

    President Biden, 79, is seen at his desk while in isolation after testing positive for COVID-19. He is taking Paxlovid and continuing to work despite mild symptoms.
    President Biden, smiling and seated at a desk, discusses COVID-19 isolation - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:Presidenthealthcarefinancial community

    By Trevor Hunnicutt, Steve Holland and Jeff Mason

    WASHINGTON (Reuters) -Joe Biden, the oldest person ever to serve as president of the United States, has tested positive for COVID-19, is experiencing mild symptoms and will continue working but in isolation, the White House said on Thursday.

    Biden, 79, has a runny nose, fatigue and an occasional dry cough, symptoms which he began to experience late on Wednesday, White House physician Kevin O’Connor said in a note released on Thursday. Biden has begun taking the antiviral treatment Paxlovid, O’Connor said.

    Fully vaccinated and twice boosted, Biden said he was “doing well” in a video posted on his Twitter account. In the 21-second clip, he also said he was “getting a lot of work done” and would continue with his duties.

    A photograph on his Twitter account showed him smiling, wearing a blazer and sitting at a desk with papers.

    White House COVID coordinator, Dr. Ashish Jha, said Biden’s oxygen levels were normal and the president would isolate for five days and return to public events once he had a negative COVID test.

    Biden became ill at a time when his administration is grappling with soaring inflation, global supply challenges, mass shootings and Russia’s land assault on Ukraine.

    His illness forced cancellation of a trip to Pennsylvania where Biden intended to lay out plans to ask Congress for $37 billion for crime prevention programs.

    The White House provided an unusually detailed account of the president’s morning activities, including a series of phone calls to political allies, and said people who had come into close contact with Biden were being told of his illness.

    Vice President Kamala Harris was in close contact with Biden on Tuesday, a White House official said. Biden’s chief of staff, Ron Klain, told MSNBC he was as well, but he said that so far no one linked to the president’s case had tested positive.

    PAXLOVID

    The Pfizer Inc antiviral drug Paxlovid that Biden is taking has been shown to reduce the risk of severe disease by nearly 90% in high risk patients if given within the first five days of infection.

    But Paxlovid has in some cases been associated with rebound infections, in which patients improve quickly and test negative after a five-day course of the drug, with symptoms returning days later.

    Dr. Bruce Farber, chief of infectious diseases at Northwell Health in New York, who is not treating the president, said Paxlovid is likely the only treatment Biden will get, unless his symptoms worsen.

    “Elderly people are more at risk for developing complications from COVID,” Farber said. “It dramatically is lower if you’ve been vaccinated and doubly boosted, which he has been, so I anticipate he will do very well.”

    At Biden’s last physical in November 2021, doctors reported that the president has atrial fibrillation, a common irregular heartbeat for which he takes Eliquis, a drug designed to prevent blood clots and reduce the risk of heart attacks and stroke.

    Jha said Biden will stop taking Eliquis and the statin Crestor while on his Paxlovid treatment to avoid a negative interaction between the drugs.

    Yale University cardiologist Dr. Harlan Krumholz, said doctors had to balance risks in medicine.

    “Sometimes the choice to mitigate one thing may elevate risk for something else. I am hopeful that the president will get through COVID, be helped by Paxlovid, and soon get back on the medication that reduces his risk from atrial fibrillation,” he said.

    OFFICIAL WASHINGTON NOT IMMUNE

    Multiple members of Biden’s administration and other senior figures in Washington have tested positive for the coronavirus in recent months, including Harris and House of Representatives Speaker Nancy Pelosi, both of whom have since tested negative and resumed working.

    While many Americans have moved on from the strict precautions of the pandemic’s early months, returning to offices and schools and resuming summer travel, the virus has been spreading rapidly.

    U.S. cases are up more than 25% in the last month, according to CDC data, with the BA.5 subvariant taking hold.

    Evading the immune protection afforded either by vaccination or prior infection, BA.5 has been the dominant subvariant in the United States since at least early July and has driven a surge of new infections globally.

    More than 1 million people have died from COVID in the United States. Most of those deaths, some 600,000, happened after Biden took office in January 2021 at the peak of a major wave of the disease.

    ‘GET VACCINATED NOW’

    Biden set up strict COVID-19 safety protocols at the White House, urged Americans to take the virus seriously and campaigned for everyone to get fully vaccinated.

    He is tested regularly for the disease and anyone who meets with him or travels with him is tested beforehand, the White House has said. Biden had last tested negative on Tuesday.

    He has stopped wearing a mask at public events in recent months, and the White House dropped its mask requirement ahead of his March 1 State of the Union address.

    Asked by Reuters on Wednesday what the country should do with COVID cases on the rise, Biden encouraged vaccination for those who had yet to get the vaccine.

    “It’s not in their interest or the public’s interest not to get vaccinated,” Biden told reporters at Joint Base Andrews. “We have the capacity to control it. They should get vaccinated now.”

    Chinese President Xi Jinping wished Biden a speedy recovery, state broadcaster CCTV reported on Friday.

    Biden joins a roster of world leaders who have contracted COVID since the pandemic started in early 2020.

    A month before he lost the 2020 presidential election to Biden, Donald Trump contracted the virus. He, his wife Melania and other White House staff contracted it after an event for Supreme Court Justice Amy Coney Barrett in September 2020.

    Trump, then 74, was hospitalized on Oct. 2, 2020, and underwent aggressive treatment at Walter Reed National Military Medical Center in a suburb of Washington. His low oxygen levels alarmed his medical team.

    Dr. Jeremy Faust, an emergency medicine specialist at Brigham and Women’s Hospital, wrote on Twitter: “Biden isn’t remotely in the same risk category as Trump was. He’s had 4 doses of vaccine, Paxlovid, and possibly a variant which tends to cause less severe disease. He also doesn’t have obesity.”

    (Reporting by Trevor Hunnicutt and Steve Holland; Additional reporting by Chris Gallagher, Nandita Bose, Susan Heavey, Michael Erman, Julie Steenhuysen and Eric Beech; Writing by Scott Malone and Ross Colvin; Editing by Chizu Nomiyama and Howard Goller)

    Frequently Asked Questions about Biden says he is ‘doing well,’ working after testing positive for COVID

    1What is Paxlovid?

    Paxlovid is an antiviral medication developed by Pfizer used to treat COVID-19. It has been shown to reduce the risk of severe disease by nearly 90% in high-risk patients if administered within the first five days of infection.

    2What is COVID-19?

    COVID-19 is a respiratory illness caused by the coronavirus SARS-CoV-2. It can lead to severe respiratory symptoms and has resulted in a global pandemic since its emergence in late 2019.

    3What is a negative COVID test?

    A negative COVID test result indicates that a person does not currently have an active COVID-19 infection, allowing them to return to public activities or events after isolation.

    More from Top Stories

    Explore more articles in the Top Stories category

    Image for Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Image for Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Image for Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Image for Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Image for Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Image for Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Image for Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Image for PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    Image for A Notable Update for Employee Health Benefits:
    A Notable Update for Employee Health Benefits:
    Image for Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Image for Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Image for ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    View All Top Stories Posts
    Previous Top Stories PostHeatwaves to menace China as almanac’s ‘big heat’ day looms
    Next Top Stories PostUK retail sales slip in June as consumers struggle with inflation